Genetic polymorphisms and lipoprotein responses to diets.
Identifieur interne : 000200 ( PubMed/Curation ); précédent : 000199; suivant : 000201Genetic polymorphisms and lipoprotein responses to diets.
Auteurs : Stephanie Vincent [France] ; Richard Planells ; Catherine Defoort ; Marie-Christine Bernard ; Mariette Gerber ; Joanne Prudhomme ; Philippe Vague ; Denis LaironSource :
- The Proceedings of the Nutrition Society [ 0029-6651 ] ; 2002.
English descriptors
- KwdEn :
- Apolipoproteins A (genetics), Apolipoproteins B (genetics), Apolipoproteins E (genetics), Cardiovascular Diseases (prevention & control), Carrier Proteins (genetics), Diet, Environment, Fatty Acid-Binding Proteins, Genetic Predisposition to Disease, Humans, Lipoproteins (blood), Neoplasm Proteins, Polymorphism, Genetic, Tumor Suppressor Proteins.
- MESH :
- chemical , blood : Lipoproteins.
- chemical , genetics : Apolipoproteins A, Apolipoproteins B, Apolipoproteins E, Carrier Proteins.
- prevention & control : Cardiovascular Diseases.
- Diet, Environment, Fatty Acid-Binding Proteins, Genetic Predisposition to Disease, Humans, Neoplasm Proteins, Polymorphism, Genetic, Tumor Suppressor Proteins.
Abstract
While human diets have markedly evolved since their origin, the human genome has only marginally changed. Nevertheless, polymorphisms of common genes are widespread. It has been substantiated that most major diseases (including cardiovascular disease, diabetes, obesity and cancers) result from the interaction between genetic susceptibility and environmental factors, including diet. In the field of lipoprotein metabolism and cardiovascular disease several gene polymorphisms for key proteins, such as apoproteins (apo) E, B, A-IV and C-III, LDL receptor, microsomal transfer protein (MTP), fatty acid-binding protein (FABP), cholesteryl ester transfer protein (CETP), lipoprotein lipase and hepatic lipase, have been identified and linked to variable responses to diets. We are carrying out an intervention study (RIVAGE) in Marseille dedicated to investigating the interactions between diets (Mediterranean or low-fat types v. standard Western type), risk factors for cardiovascular disease and gene polymorphisms in about 300 patients randomized into two groups over periods of 3 and 12 months. Some data obtained in about 100 patients after 3 months of dietary change are available. Among single nucleotide polymorphisms (SNP) already studied (apoE (epsilon2, epsilon3, epsilon4), apoB (-516C/T), apoC-III (SstI), apoA-IV (Ser347Thr), MTP (-493G/T), intestinal FABP (Ala54Thr), CETP (TaqIB) and hepatic lipase (-480C/T)), some SNP showed interactions with diets in relation to changes in particular variables after 3 months on the dietary regimens. This was the case for apoE and LDL-cholesterol and triacylglycerols, apoA-IV and LDL-cholesterol, MTP and LDL-cholesterol, intestinal FABP and triacylglycerols. These data provide evidence of the interaction between some SNP and the metabolic response to diets.
PubMed: 12691171
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000200
Links to Exploration step
pubmed:12691171Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Genetic polymorphisms and lipoprotein responses to diets.</title>
<author><name sortKey="Vincent, Stephanie" sort="Vincent, Stephanie" uniqKey="Vincent S" first="Stephanie" last="Vincent">Stephanie Vincent</name>
<affiliation wicri:level="1"><nlm:affiliation>Unité 476-Human Nutrition and Lipids at INSERM (National Institute of Health and Medical Research), 18 Avenue Mozart, 13009 Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité 476-Human Nutrition and Lipids at INSERM (National Institute of Health and Medical Research), 18 Avenue Mozart, 13009 Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Planells, Richard" sort="Planells, Richard" uniqKey="Planells R" first="Richard" last="Planells">Richard Planells</name>
</author>
<author><name sortKey="Defoort, Catherine" sort="Defoort, Catherine" uniqKey="Defoort C" first="Catherine" last="Defoort">Catherine Defoort</name>
</author>
<author><name sortKey="Bernard, Marie Christine" sort="Bernard, Marie Christine" uniqKey="Bernard M" first="Marie-Christine" last="Bernard">Marie-Christine Bernard</name>
</author>
<author><name sortKey="Gerber, Mariette" sort="Gerber, Mariette" uniqKey="Gerber M" first="Mariette" last="Gerber">Mariette Gerber</name>
</author>
<author><name sortKey="Prudhomme, Joanne" sort="Prudhomme, Joanne" uniqKey="Prudhomme J" first="Joanne" last="Prudhomme">Joanne Prudhomme</name>
</author>
<author><name sortKey="Vague, Philippe" sort="Vague, Philippe" uniqKey="Vague P" first="Philippe" last="Vague">Philippe Vague</name>
</author>
<author><name sortKey="Lairon, Denis" sort="Lairon, Denis" uniqKey="Lairon D" first="Denis" last="Lairon">Denis Lairon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12691171</idno>
<idno type="pmid">12691171</idno>
<idno type="wicri:Area/PubMed/Corpus">000200</idno>
<idno type="wicri:Area/PubMed/Curation">000200</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Genetic polymorphisms and lipoprotein responses to diets.</title>
<author><name sortKey="Vincent, Stephanie" sort="Vincent, Stephanie" uniqKey="Vincent S" first="Stephanie" last="Vincent">Stephanie Vincent</name>
<affiliation wicri:level="1"><nlm:affiliation>Unité 476-Human Nutrition and Lipids at INSERM (National Institute of Health and Medical Research), 18 Avenue Mozart, 13009 Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité 476-Human Nutrition and Lipids at INSERM (National Institute of Health and Medical Research), 18 Avenue Mozart, 13009 Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Planells, Richard" sort="Planells, Richard" uniqKey="Planells R" first="Richard" last="Planells">Richard Planells</name>
</author>
<author><name sortKey="Defoort, Catherine" sort="Defoort, Catherine" uniqKey="Defoort C" first="Catherine" last="Defoort">Catherine Defoort</name>
</author>
<author><name sortKey="Bernard, Marie Christine" sort="Bernard, Marie Christine" uniqKey="Bernard M" first="Marie-Christine" last="Bernard">Marie-Christine Bernard</name>
</author>
<author><name sortKey="Gerber, Mariette" sort="Gerber, Mariette" uniqKey="Gerber M" first="Mariette" last="Gerber">Mariette Gerber</name>
</author>
<author><name sortKey="Prudhomme, Joanne" sort="Prudhomme, Joanne" uniqKey="Prudhomme J" first="Joanne" last="Prudhomme">Joanne Prudhomme</name>
</author>
<author><name sortKey="Vague, Philippe" sort="Vague, Philippe" uniqKey="Vague P" first="Philippe" last="Vague">Philippe Vague</name>
</author>
<author><name sortKey="Lairon, Denis" sort="Lairon, Denis" uniqKey="Lairon D" first="Denis" last="Lairon">Denis Lairon</name>
</author>
</analytic>
<series><title level="j">The Proceedings of the Nutrition Society</title>
<idno type="ISSN">0029-6651</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Apolipoproteins A (genetics)</term>
<term>Apolipoproteins B (genetics)</term>
<term>Apolipoproteins E (genetics)</term>
<term>Cardiovascular Diseases (prevention & control)</term>
<term>Carrier Proteins (genetics)</term>
<term>Diet</term>
<term>Environment</term>
<term>Fatty Acid-Binding Proteins</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Lipoproteins (blood)</term>
<term>Neoplasm Proteins</term>
<term>Polymorphism, Genetic</term>
<term>Tumor Suppressor Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Lipoproteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Apolipoproteins A</term>
<term>Apolipoproteins B</term>
<term>Apolipoproteins E</term>
<term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diet</term>
<term>Environment</term>
<term>Fatty Acid-Binding Proteins</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Neoplasm Proteins</term>
<term>Polymorphism, Genetic</term>
<term>Tumor Suppressor Proteins</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">While human diets have markedly evolved since their origin, the human genome has only marginally changed. Nevertheless, polymorphisms of common genes are widespread. It has been substantiated that most major diseases (including cardiovascular disease, diabetes, obesity and cancers) result from the interaction between genetic susceptibility and environmental factors, including diet. In the field of lipoprotein metabolism and cardiovascular disease several gene polymorphisms for key proteins, such as apoproteins (apo) E, B, A-IV and C-III, LDL receptor, microsomal transfer protein (MTP), fatty acid-binding protein (FABP), cholesteryl ester transfer protein (CETP), lipoprotein lipase and hepatic lipase, have been identified and linked to variable responses to diets. We are carrying out an intervention study (RIVAGE) in Marseille dedicated to investigating the interactions between diets (Mediterranean or low-fat types v. standard Western type), risk factors for cardiovascular disease and gene polymorphisms in about 300 patients randomized into two groups over periods of 3 and 12 months. Some data obtained in about 100 patients after 3 months of dietary change are available. Among single nucleotide polymorphisms (SNP) already studied (apoE (epsilon2, epsilon3, epsilon4), apoB (-516C/T), apoC-III (SstI), apoA-IV (Ser347Thr), MTP (-493G/T), intestinal FABP (Ala54Thr), CETP (TaqIB) and hepatic lipase (-480C/T)), some SNP showed interactions with diets in relation to changes in particular variables after 3 months on the dietary regimens. This was the case for apoE and LDL-cholesterol and triacylglycerols, apoA-IV and LDL-cholesterol, MTP and LDL-cholesterol, intestinal FABP and triacylglycerols. These data provide evidence of the interaction between some SNP and the metabolic response to diets.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">12691171</PMID>
<DateCreated><Year>2003</Year>
<Month>04</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted><Year>2003</Year>
<Month>05</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0029-6651</ISSN>
<JournalIssue CitedMedium="Print"><Volume>61</Volume>
<Issue>4</Issue>
<PubDate><Year>2002</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>The Proceedings of the Nutrition Society</Title>
<ISOAbbreviation>Proc Nutr Soc</ISOAbbreviation>
</Journal>
<ArticleTitle>Genetic polymorphisms and lipoprotein responses to diets.</ArticleTitle>
<Pagination><MedlinePgn>427-34</MedlinePgn>
</Pagination>
<Abstract><AbstractText>While human diets have markedly evolved since their origin, the human genome has only marginally changed. Nevertheless, polymorphisms of common genes are widespread. It has been substantiated that most major diseases (including cardiovascular disease, diabetes, obesity and cancers) result from the interaction between genetic susceptibility and environmental factors, including diet. In the field of lipoprotein metabolism and cardiovascular disease several gene polymorphisms for key proteins, such as apoproteins (apo) E, B, A-IV and C-III, LDL receptor, microsomal transfer protein (MTP), fatty acid-binding protein (FABP), cholesteryl ester transfer protein (CETP), lipoprotein lipase and hepatic lipase, have been identified and linked to variable responses to diets. We are carrying out an intervention study (RIVAGE) in Marseille dedicated to investigating the interactions between diets (Mediterranean or low-fat types v. standard Western type), risk factors for cardiovascular disease and gene polymorphisms in about 300 patients randomized into two groups over periods of 3 and 12 months. Some data obtained in about 100 patients after 3 months of dietary change are available. Among single nucleotide polymorphisms (SNP) already studied (apoE (epsilon2, epsilon3, epsilon4), apoB (-516C/T), apoC-III (SstI), apoA-IV (Ser347Thr), MTP (-493G/T), intestinal FABP (Ala54Thr), CETP (TaqIB) and hepatic lipase (-480C/T)), some SNP showed interactions with diets in relation to changes in particular variables after 3 months on the dietary regimens. This was the case for apoE and LDL-cholesterol and triacylglycerols, apoA-IV and LDL-cholesterol, MTP and LDL-cholesterol, intestinal FABP and triacylglycerols. These data provide evidence of the interaction between some SNP and the metabolic response to diets.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vincent</LastName>
<ForeName>Stephanie</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Unité 476-Human Nutrition and Lipids at INSERM (National Institute of Health and Medical Research), 18 Avenue Mozart, 13009 Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Planells</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Defoort</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bernard</LastName>
<ForeName>Marie-Christine</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gerber</LastName>
<ForeName>Mariette</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Prudhomme</LastName>
<ForeName>Joanne</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vague</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lairon</LastName>
<ForeName>Denis</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Proc Nutr Soc</MedlineTA>
<NlmUniqueID>7505881</NlmUniqueID>
<ISSNLinking>0029-6651</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001054">Apolipoproteins A</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001055">Apolipoproteins B</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C107608">FABP7 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050556">Fatty Acid-Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008074">Lipoproteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009363">Neoplasm Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025521">Tumor Suppressor Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C022205">apolipoprotein A-IV</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001054">Apolipoproteins A</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001055">Apolipoproteins B</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001057">Apolipoproteins E</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002352">Carrier Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D004032">Diet</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004777">Environment</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D050556">Fatty Acid-Binding Proteins</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020022">Genetic Predisposition to Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008074">Lipoproteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D009363">Neoplasm Proteins</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D011110">Polymorphism, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D025521">Tumor Suppressor Proteins</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>36</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2003</Year>
<Month>5</Month>
<Day>3</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2003</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12691171</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/MozartV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000200 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000200 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Musique |area= MozartV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:12691171 |texte= Genetic polymorphisms and lipoprotein responses to diets. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:12691171" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MozartV1
![]() | This area was generated with Dilib version V0.6.20. | ![]() |